返回
Livzon Pharmaceutical Group Inc.（01513.HK）價格
01513.HK 股價走勢圖
LIVZON PHARMA (01513.HK)
Livzon Pharmaceutical Group Inc.
HK$0
0%
$0
休市： Jan 29, 16:00:00 HKT
暫無資料Follow-Up Questions
Livzon Pharmaceutical Group Inc. 的關鍵財務報表是什麼？
01513.HK 的關鍵財務比率是什麼？
Livzon Pharmaceutical Group Inc. 的收入按細分市場或地理位置如何劃分？
Livzon Pharmaceutical Group Inc. 是否盈利？
Livzon Pharmaceutical Group Inc. 有負債嗎？
Livzon Pharmaceutical Group Inc. 的流通股有多少？
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
738.2K
每股盈餘 (TTM)
2.64
股息收益率
--
市值
--
什麼是 LIVZON PHARMA？
Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 9,067 full-time employees. Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The firm's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The firm's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The firm mainly operates its businesses in the domestic and overseas markets.